semaglutide effect on blood pressure and High Pressure: Effects and Management Meta-analysis of the Effect of

Compounding pharmacies must have the proper licensed facilities and comply with state and federal regulations before dispensing these medications

[DOI] [PMC free article] [PubMed] [Google Scholar] Imeryz N., Yeen B.., Bozkurt A., Cokun T., Villanueva-Peacarrillo M.L., Ulusoy N.B

Other Medications: Some patients may benefit from combining semaglutide with other metabolic supports, but this is only done under strict supervision to avoid hypoglycemia (low blood sugar), especially if you are already taking insulin or sulfonylureas

10.1007/s001250050903 11 Emerging Risk Factors CollaborationWormserD.KaptogeS.Di AngelantonioE.WoodA

What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass

Interaction terms between treatment and key baseline factors (e.g., baseline epigenetic age acceleration or baseline BMI) were explored to see if the treatment effect varied by these factors